Krzysztof S. Gołba

Medical University of Silesia

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (14)

Jacek Durmała

Head

Medical University of Silesia

POLAND

View details

Beata Sarecka-Hujar

Medical University of Silesia, Faculty of Pharmaceutical Sciences in Sosnowiec

POLAND

View details

Michał Gibiński

Medical University of Silesia

POLAND

View details

Marta Nowacka-Chmielewska

Medical University of Silesia

POLAND

View details

Jacek F. Wilczek

Medical University of Silesia

POLAND

View details

Rafał Gardas

Medical University of Silesia

POLAND

View details

Tomasz Jadczyk

Medical University of Silesia

POLAND

View details

Marcin Miszczyk

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Konrad Kaminiów

WSB University

POLAND

View details

Karolina Simionescu

Medical University of Silesia

POLAND

View details

Krystian Wita

Medical University of Silesia

POLAND

View details

Angelo Auricchio

Università del Salento

SWITZERLAND

View details

Mateusz Lejawa

Research and Teaching Assistant

Medical University of Silesia

POLAND

View details

Rafal Mlynarski

Professor

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Krzysztof S. Gołba

Research Interests

Explore related searches

Contact this professor

Articles (20)

Variability in Arterial Stiffness and Vascular Endothelial Function After COVID-19 During 1.5 Years of Follow-Up—Systematic Review and Meta-Analysis

Variability in Arterial Stiffness and Vascular Endothelial Function After COVID-19 During 1.5 Years of Follow-Up-Systematic Review and Meta-Analysis

The regional distribution of catheter ablations of atrial fibrillation and atrial flutter in Poland in 2023

Relationship of Non-Invasive Arterial Stiffness Parameters with 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Post-COVID-19 Patients—The Results of a Cross-Sectional Study

Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre

Relationship of Non-Invasive Arterial Stiffness Parameters with 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Post-COVID-19 Patients-The Results of a Cross-Sectional Study

Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre

Do Photopletysmographic Parameters of Arterial Stiffness Differ Depending on the Presence of Arterial Hypertension and/or Atherosclerosis?

Do Photopletysmographic Parameters of Arterial Stiffness Differ Depending on the Presence of Arterial Hypertension and/or Atherosclerosis?

Cardiac status and atherosclerotic cardiovascular risk of convalescents after COVID-19 in Poland.

Long COVID-19 syndrome severity according to sex, time from the onset of the disease, and exercise capacity - the results of a cross-sectional study.

Usefulness of metal artifact reduction algorithms from the pacemaker lead in diagnosis of late perforation: The right choice makes it easier to make a decision

Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia (SMART-VT). Results of a prospective safety trial

The Usefulness of Questionnaires in Assessing the Risk of Obstructive Sleep Apnea in Patients in the Managed Care after Acute Myocardial Infarction Program—The Results of a Cross-Sectional Study

Time-related factors predicting a positive response to cardiac resynchronisation therapy in patients with heart failure

Severe sleep apnea as a predictor of failure to respond to cardiac resynchronization therapy.

Left ventricular electrical potential measured by the NOGA XP electromechanical mapping method as a predictor of response to cardiac resynchronization therapy

Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro

Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy

Collaborators (14)

Jacek Durmała

Beata Sarecka-Hujar

Michał Gibiński

Marta Nowacka-Chmielewska

Jacek F. Wilczek

Rafał Gardas

Tomasz Jadczyk

Marcin Miszczyk

Konrad Kaminiów

Karolina Simionescu

Krystian Wita

Angelo Auricchio

Mateusz Lejawa

Rafal Mlynarski

Make your next move.